REGENEREX PHARMA, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Regenerex Pharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Regenerex Pharma, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 278M shares, a 0.19% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 278M +520K +0.19% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 278M +923K +0.33% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 278M +1.11M +0.4% Mar 31, 2024 10-Q 2024-11-04
Q4 2023 278M +833K +0.3% Dec 31, 2023 10-Q 2024-02-05
Q3 2023 278M +803K +0.29% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 277M +220K +0.08% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 277M 0 0% Mar 31, 2023 10-K 2024-06-24
Q4 2022 277M 0 0% Dec 31, 2022 10-Q 2023-01-24
Q3 2022 277M +150M +118% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 277M +150M +118% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 277M +150M +118% Mar 31, 2022 10-K 2023-06-09
Q4 2021 277M +150M +118% Dec 31, 2021 10-Q/A 2022-02-03
Q3 2021 127M 0 0% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 127M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 127M 0 0% Mar 31, 2021 10-K 2022-06-28
Q4 2020 127M 0 0% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 127M 0 0% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 127M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 127M 0 0% Mar 31, 2020 10-K 2021-06-23
Q4 2019 127M 0 0% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 127M 0 0% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 127M 0 0% Jun 30, 2019 10-Q/A 2019-07-29
Q1 2019 127M 0 0% Mar 31, 2019 10-K/A 2020-08-11
Q4 2018 127M +10.3M +8.77% Dec 31, 2018 10-Q 2019-02-04
Q3 2018 127M -29M -18.6% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 127M -29M -18.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 127M -29M -18.6% Mar 31, 2018 10-K 2019-06-24
Q4 2017 117M Dec 31, 2017 10-Q 2018-02-08
Q3 2017 156M Sep 30, 2017 10-Q 2017-11-07
Q2 2017 156M Jun 30, 2017 10-Q 2017-08-07
Q1 2017 156M Mar 31, 2017 10-K 2018-06-21
Q4 2014 156M +156M Nov 30, 2014 10-K 2015-03-03
Q3 2014 156M Aug 31, 2014 10-Q 2014-10-20
Q2 2014 4.66K* -20.3K Jul 15, 2014 10-K 2015-03-03
Q1 2014 10K* -10K Apr 3, 2014 10-K 2015-03-03
Q4 2013 10K* -149M Dec 5, 2013 10-K 2015-03-03
Q2 2013 25K* -141M Jul 18, 2013 10-K 2015-03-03
Q1 2013 20K* Apr 10, 2013 10-K 2015-03-03
Q4 2012 149M -21.9M -12.8% Nov 30, 2012 10-K 2014-02-28
Q3 2012 146M -24.9M -14.6% Aug 31, 2012 10-Q 2012-10-15
Q2 2012 141M May 31, 2012 10-Q 2012-07-16
Q4 2011 171M +75M +78.1% Nov 30, 2011 10-K/A 2013-02-28
Q3 2011 171M Aug 31, 2011 10-Q 2011-10-13
Q4 2010 96M Nov 30, 2010 10-Q 2011-10-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.